Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]

#VisualAbstract: Antibody NI006 for treatment of transthyretin amyloid cardiomyopathy caused no serious adverse events

Sep 15, 2023

ABOUT THE EXPERTS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
[adinserter block="22" template="Article Pages" check="exceptions" ignore="page-type"]
ad
[adinserter block="23" template="Article Pages" check="exceptions" ignore="page-type"]
Advertisement
[adinserter block="4" template="Article Pages" check="exceptions" ignore="page-type"]